A novel inflammatory role for platelets in sickle cell disease

Platelets

Volumn 26, Issue 8, 2015, Pages 726-729

  Davila, Jennifer ^a   Manwani, Deepa ^b   Vasovic, Ljiljana ^c   Avanzi, Mauro ^d   Uehlinger, Joan ^c   Ireland, Karen ^b   Mitchell, W Beau ^d,e  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b CHILDREN S HOSPITAL AT MONTEFIORE   (United States)

^c MONTEFIORE MEDICAL CENTER   (United States)

^d NEW YORK BLOOD CENTER   (United States)

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Cytokines; inflammation; platelet activation; platelets; sickle cell disease

Indexed keywords

ALLOANTIBODY; CD40 LIGAND; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; BIOLOGICAL MARKER; CYTOKINE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; CYTOKINE RELEASE; DISEASE ASSOCIATION; HUMAN; INFLAMMATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SICKLE CELL ANEMIA; TH1 CELL; TH17 CELL; TH2 CELL; THROMBOCYTE ACTIVATION; THROMBOCYTE RELEASE REACTION; ANEMIA, SICKLE CELL; BLOOD; COMPLICATION; GENE EXPRESSION; GENETICS; METABOLISM; THROMBOCYTE; YOUNG ADULT;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; BIOMARKERS; BLOOD PLATELETS; CYTOKINES; GENE EXPRESSION; HUMANS; INFLAMMATION MEDIATORS; PLATELET ACTIVATION; RNA, MESSENGER; YOUNG ADULT;

EID: 84942983615     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537104.2014.983891     Document Type: Article

References (31)

1. Manwani D, Frenette PS. Vaso-occlusion in sickle cell disease: Pathophysiology and novel targeted therapies. Blood 2013;122: 3892-3898.
2. Hendrickson JE, Desmarets M, Deshpande SS, Chadwick TE, Hillyer CD, Roback JD, Zimring JC. Recipient inflammation affects the frequency and magnitude of immunization to transfused red blood cells. Transfusion 2006;46:1526-1536.
3. Habets KL, Huizinga TW, Toes RE. Platelets and autoimmunity. Eur J Clin Invest 2013;43:746-757.
4. De Franceschi L, Cappellini MD, Olivieri O. Thrombosis and sickle cell disease. Semin Thromb Hemost 2011;37:226-236.
5. Lee SP, Ataga KI, Orringer EP, Phillips DR, Parise LV. Biologically active CD40 ligand is elevated in sickle cell anemia: Potential role for platelet-mediated inflammation. Arteriosclerosis, Thrombosis, Vasc Biol 2006;26:1626-1631.
6. Wun T, Paglieroni T, Tablin F, Welborn J, Nelson K, Cheung A. Platelet activation and platelet-erythrocyte aggregates in patients with sickle cell anemia. J Lab Clin Med 1997;129:507-516.
7. Tantawy AA, Adly AA, Ismail EA, Habeeb NM, Farouk A. Circulating platelet and erythrocyte microparticles in young children and adolescents with sickle cell disease: Relation to cardiovascular complications. Platelets 2013;24:605-614.
8. Wun T, Paglieroni T, Rangaswami A, Franklin PH, Welborn J, Cheung A, Tablin F. Platelet activation in patients with sickle cell disease. Br J Haematol 1998;100:741-749.
9. Lindemann S, Tolley ND, Dixon DA, McIntyre TM, Prescott SM, Zimmerman GA, Weyrich AS. Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis. J Cell Biol 2001;154:485-490.
10. Antczak AJ, Singh N, Gay SR, Worth RG. IgG-complex stimulated platelets: a source of sCD40L and RANTES in initiation of inflammatory cascade. Cell Immunol 2010;263:129-133.
11. Meyer A, Wang W, Qu J, Croft L, Degen JL, Coller BS, Ahamed J. Platelet TGF-beta1 contributions to plasma TGF-beta1, cardiac fibrosis, and systolic dysfunction in a mouse model of pressure overload. Blood 2012;119:1064-1074.
12. Lindemann S, Tolley ND, Dixon DA, McIntyre TM, Prescott SM, Zimmerman GA, Weyrich AS. Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis. J Cell Biol 2001;154:485-490.
13. Pitchford SC. Novel uses for anti-platelet agents as anti-inflammatory drugs. Br J Pharmacol 2007;152:987-1002.
14. Antoniades C, Bakogiannis C, Tousoulis D, Demosthenous M, Marinou K, Stefanadis C. Platelet activation in atherogenesis associated with low-grade inflammation. Inflamm Allergy Drug Targets 2010;9:334-345.
15. McNicol A, Israels SJ. Beyond hemostasis: The role of platelets in inflammation, malignancy and infection. Cardiovasc Hematol Disord Drug Targets 2008;8:99-117.
16. Zimmerman GA, Weyrich AS. Signal-dependent protein synthesis by activated platelets: New pathways to altered phenotype and function. Arteriosclerosis, Thrombosis, Vasc Biol 2008;28: s17-s24.
17. Pfaffl MW, Horgan GW, Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acid Res 2002; 30:e36.
18. Beaulieu LM, Lin E, Mick E, Koupenova M, Weinberg EO, Kramer CD, Genco CA, Tanriverdi K, Larson MG, Benjamin EJ, et al. Interleukin 1 receptor 1 and interleukin 1beta regulate megakaryocyte maturation, platelet activation, and transcript profile during inflammation in mice and humans. Arterioscler Thromb Vasc Biol [Research Support, N. I. H., Extramural] 2014;34:552-564.
19. McManus DD, Beaulieu LM, Mick E, Tanriverdi K, Larson MG, Keaney Jr JF, Benjamin EJ, Freedman JE. Relationship among circulating inflammatory proteins, platelet gene expression, and cardiovascular risk. Arterioscler Thromb Vasc Biol [Research Support, N. I. H., Extramural] 2013;33:2666-2673.
20. Frelinger 3rd AL, Jakubowski JA, Brooks JK, Carmichael SL, Berny-Lang MA, Barnard MR, Heeney MM, Michelson AD. Platelet activation and inhibition iN sickle cell disease (PAINS) study. Platelets 2014;25:27-35.
21. Vichinsky EP, Earles A, Johnson RA, Hoag MS, Williams A, Lubin B. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. N Engl J Med 1990;322:1617-1621.
22. Liu CC, Wang SC, Kao CW, Hsieh RK, Chang MC, Chang YF, Lim KH, Chen CG. B cells facilitate platelet production mediated by cytokines in patients with essential thrombocythaemia. Thromb Haemost 2014;112:537-550.
23. Ryffel B, Mihatsch MJ, Woerly G. Pathology induced by interleukin-6. Int Rev Exp Pathol 1993;34 Pt A:79-89.
24. Int Rev Exp Pathol 1993;34 Pt A:79-89.
25. Baatout S. Interleukin-6 and megakaryocytopoiesis: An update. Ann Hematol 1996;73:157-162.
26. Raghavachari N, Xu X, Harris A, Villagra J, Logun C, Barb J, Solomon MA, Suffredini AF, Danner RL, Kato G, et al. Amplified expression profiling of platelet transcriptome reveals changes in arginine metabolic pathways in patients with sickle cell disease. Circulation 2007;115:1551-1562.
27. Chaplin Jr H, Alkjaersig N, Fletcher AP, Michael JM, Joist JH. Aspirin-dipyridamole prophylaxis of sickle cell disease pain crises. Thromb Haemost 1980;43:218-221.
28. Osamo NO, Photiades DP, Famodu AA. Therapeutic effect of aspirin in sickle cell anaemia. Acta Haematol 1981;66:102-107.
29. Greenberg J, Ohene-Frempong K, Halus J, Way C, Schwartz E. Trial of low doses of aspirin as prophylaxis in sickle cell disease. J Pediatr 1983;102:781-784.
30. Wun T, Soulieres D, Frelinger AL, Krishnamurti L, Novelli EM, Kutlar A, Ataga KI, Knupp CL, McMahon LE, Strouse JJ, et al. A double-blind, randomized, multicenter phase 2 study of prasugrel versus placebo in adult patients with sickle cell disease. J Hematol Oncol 2013;6:17. Published online Feb 17, 2013. doi: 10. 1186/1756-8722-6-17.
31. Pitchford SC. Novel uses for anti-platelet agents as anti-inflammatory drugs. Br J Pharmacol 2007;152:987-1002.